Defensive plays to navigate tariff tensions
Defensive plays to navigate tariff tensions
About this video
Key points:
Importance of a defensive investment strategy with unresolved tariffs.
Shifts in tech with Apple's potential move from Google to AI alternatives.
Opportunities in pharmaceuticals, focusing on GLP-1 weight loss drugs and strategic tariff positioning.
Sam Ruiz from T. Rowe Price shares insights on current market movements amidst unresolved tariffs, suggesting a defensive approach with investments in consumer staples, utilities, and insurance companies. He notes the strength in quarterly earnings, despite looming tariff concerns.
Sam points out changing dynamics in tech, highlighting Apple’s shift from Google to potentially using AI search engines like Perplexity. He mentions his company's decreased exposure to mega-cap tech and increased interest in emerging markets and Europe.
On the pharmaceutical front, Sam sees potential in companies like Eli Lilly (NYSE: LLY) and Shanghai Pharmaceutical (SHA: 601607). He highlights opportunities in GLP-1 weight loss drugs, underscoring the strategic advantage of avoiding US tariffs while tapping into potential royalty streams.